Biocryst Pharmaceuticals Inc
UnclaimedPharmaceutical Preparation ManufacturingDurham, NC
Founded
1991
Primary NAICS
325412
CAGE code
4GBX7
Federal awards
—
Overview
We are BioCryst, a different kind of biotech company. Learn about our commitment to the rare disease patient community and discover career opportunities.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Research and Development in Biotechnology (except Nanobiotechnology)Drugs and BiologicalsHealth R&D Services; Health Care Services; Basic ResearchHealth R&D Services; Health Care Services; Experimental Development
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Veterans Affairs | $6,624 | 12 |
| 2026 | Department of Health and Human Services | $0 | 1 |
| 2025 | Department of Veterans Affairs | $1,075,037 | 14 |
| 2025 | Department of Health and Human Services | -$29,867,448 | 3 |
| 2024 | Department of Health and Human Services | $1,578,348 | 4 |
| 2024 | Department of Veterans Affairs | $1,080,395 | 9 |
| 2023 | Department of Veterans Affairs | -$198,571 | 7 |
| 2022 | Department of Health and Human Services | $7,372,828 | 3 |
| 2022 | Department of Veterans Affairs | $453,763 | 7 |